EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 236 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2019. The put-call ratio across all filers is 4.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $14,889,000 | -11.7% | 342,494 | +1.7% | 0.15% | -11.1% |
| Q3 2021 | $16,857,000 | -22.0% | 336,680 | -1.9% | 0.17% | -21.9% |
| Q2 2021 | $21,610,000 | -57.0% | 343,055 | -36.5% | 0.22% | -59.2% |
| Q1 2021 | $50,229,000 | -14.8% | 540,620 | -17.8% | 0.54% | -22.2% |
| Q4 2020 | $58,935,000 | +112.0% | 657,766 | +144.5% | 0.69% | +78.3% |
| Q3 2020 | $27,801,000 | +79.5% | 269,057 | +37.3% | 0.39% | +74.3% |
| Q2 2020 | $15,491,000 | +3.0% | 195,896 | -24.6% | 0.22% | -13.6% |
| Q1 2020 | $15,041,000 | -26.3% | 259,955 | -31.3% | 0.26% | +0.8% |
| Q4 2019 | $20,415,000 | -42.4% | 378,416 | -44.2% | 0.26% | -46.2% |
| Q3 2019 | $35,426,000 | +28.3% | 677,628 | +18.6% | 0.47% | +29.5% |
| Q2 2019 | $27,605,000 | +3.6% | 571,409 | +8.3% | 0.37% | +2.5% |
| Q1 2019 | $26,644,000 | – | 527,400 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
| Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
| AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
| Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
| Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
| SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
| EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
| PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |